Germany· DE-A57-2f5811bc40c119aa
Neuroderm Akut
A hydrocortisone butyrate product containing hydrocortisone butyrate propionate, registered in Germany by Infectopharm Arzneimittel Und Consilium Gmbh, De, Heppenheim. The same ATC class is registered in 13 of our 19 countries.
Checked against EMA Article 57 (European Union) on
Informational only — not a medical device.
Where it is registered
Hydrocortisone butyrate is registered in 13 of 19 countries.
Countries holding a registration under ATC D07AB02 (hydrocortisone butyrate), each read from that country’s own register.
- This record: Germany, from EMA Article 57 (European Union)
- 8 of them publish a price we can compare per daily dose
Hydrocortisone butyrate · ATC D07AB02
13 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Germany
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
EMA Article 57 (European Union)- Active substance
- Hydrocortisone Butyrate Propionate
- Manufacturer
- Infectopharm Arzneimittel Und Consilium Gmbh, De, Heppenheim
- Country
- Germany (DE)
- ATC code
- D07AB02
- ATC class
- Hydrocortisone butyrate
- Reimbursed
- Not published by this register
- Source register
- EMA Article 57 (European Union)
- Last checked
- September 30, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
55 interactions on record for hydrocortisone butyrate.
Graded by severity as the source publishes them — 55 minor. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Hydrocortisone butyrate · interactions on record
55 records
Same class
Other records under D07AB02
Hydrocortisone butyrate, as other registers publish it.
- NorwayAlfasonCheplapharm
- GermanyAlfason CreloCheplapharm Arzneimittel Gmbh
- GermanyAlfason CremeCheplapharm Arzneimittel Gmbh
- GermanyAlfason CresaCheplapharm Arzneimittel Gmbh
- GermanyAlfason CrinaleCheplapharm Arzneimittel Gmbh
- GermanyAlfason SalbeCheplapharm Arzneimittel Gmbh
- FinlandBucortOrion Corporation Orion Pharma
- FinlandBucortOrion Corporation Orion Pharma
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of EMA Article 57 (European Union). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/3ce1e9c1-8760-40d3-ac9f-951de6b06768 GET /v1/drugs/3ce1e9c1-8760-40d3-ac9f-951de6b06768?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"pzn": null,
"route": "Cutaneous Use",
"source": "ema_art57_de",
"ma_number": null,
"substance": "Hydrocortisone Butyrate Propionate",
"atc_from_source": null,
"authorisation_country": "Germany"
}See everything about hydrocortisone butyrate.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.